Drug name - Linzess

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7371727 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Jan, 2024

(1 year, 1 month from now)

US7704947 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Jan, 2024

(1 year, 1 month from now)

US8080526 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Jan, 2024

(1 year, 1 month from now)

US7745409 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Jan, 2024

(1 year, 1 month from now)

US7304036 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Aug, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8110553 ALLERGAN Methods and compositions for the treatment of gastrointestinal disorders
Jan, 2024

(1 year, 1 month from now)

US8933030 ALLERGAN Treatments for gastrointestinal disorders
Feb, 2031

(8 years from now)

US10702576 ALLERGAN Stable formulations of linaclotide
Aug, 2031

(8 years from now)

US10675325 ALLERGAN Stable formulations of linaclotide
Aug, 2031

(8 years from now)

US8748573 ALLERGAN Formulations comprising linaclotide
Oct, 2031

(8 years from now)

US8802628 ALLERGAN Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
Oct, 2031

(8 years from now)

US9708371 ALLERGAN Treatments for gastrointestinal disorders
Aug, 2033

(10 years from now)

Drugs and Companies using LINACLOTIDE ingredient

Market Authorisation Date: 30 August, 2012

Treatment: Method of treating irritable bowel syndrome with constipation in adults; Method of treating chronic idiopathic constipation in adult patients.; Method of treating irritable bowel syndrome with constipation in adult patients.

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
72MCG CAPSULE;ORAL Prescription
145MCG CAPSULE;ORAL Prescription
290MCG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.